GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...
GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...
Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...
This new paradigm of pre-emptive risk management should be centred on AI-enabled data analysis, according to Colin Shelton, ...
Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...
Melrose Industries shares were the top blue-chip performer on Monday after the company reaffirmed annual guidance despite industry-wide supply chain issues. The FTSE 100 owner of GSK Aerospace ...
The site will house around 3,000 people – including GSK's global leadership team, and teams supporting R&D, the supply chain, commercial operations, corporate functions, and HIV joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback